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Summary
Introduction: Mediterranean spotted fever (MSF) due to Rickettsia conorii is the most important
tick-borne disease occurring in North Africa. However, there are only a few fragmentary reports on
the epidemiology and clinical aspects of rickettsioses in North Africa, and cases are still rarely
documented. We report herein a prospective study conducted in Oran, the second largest city in
Algeria. This disease has not been properly described in Oran or in other Algerian cities.
Methods: A total of 167 cases of Mediterranean spotted fever were documented for the first time
by the use of reference methods including immunofluorescence serology and Western blot and
absorption studies, including isolation in culture by the shell-vial techniques, and molecular tools.
Results: Although some aspects of MSF were found to be in accordance with the general
epidemiology of the disease, uncommon aspects were found, including increased incidence and
the presence of multiple inoculation eschars in 12% of patients. The role of climatic changes in
alterations of host-seeking and feeding behaviors of the vectors, including the brown dog tick
Rhipicephalus sanguineus, is discussed. Also, 49% of patients were hospitalized with a severe form.
The global death rate was 3.6%, but it was 54.5% in patients hospitalized with major neurological
manifestations and multiorgan involvement.
Conclusions: The present report gives a unique panel of clinical aspects of MSF as well as new
trends in this disease. Entomological, climatic, and molecular studies are needed to better
understand both epidemiological and clinical aspects of MSF.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +33 (0)4 91 32 43 75;
fax: +33 (0)4 91 38 77 72.
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Tick-borne rickettsioses are caused by the obligate intracel-
lular bacteria spotted fever group (SFG) Rickettsia sppwithin
the family Rickettsiaceae in the order Rickettsiales.1 These
zoonoses are among the oldest known vector-borne diseases,
but they are also now recognized as emerging or reemergingPublished by Elsevier Ltd. All rights reserved.
228 N. Mouffok et al.human infections worldwide, with a dozen new tick-borne
rickettsial species or subspecies recognized as human patho-
gens since 1984.1,2 These diseases share characteristic clin-
ical features, including fever, rash, and sometimes an
inoculation eschar at the bite site, depending on the rick-
ettsial agent that is involved.1
The first case of Mediterranean spotted fever (MSF) was
reported in Tunisia, North Africa in 1910.3 In the 1930s, the
role of the brown dog tick, Rhipicephalus sanguineus, and the
causative agent (Rickettsia conorii) were described.4
Recently, the nomenclature of the several strains recognized
as belonging to the so-called R. conorii complex has been
modified and several species have been named including R.
conorii subsp. conorii subsp. nov. (type strain = Malish, ATCC
VR-613), the agent of MSF.5
There are only a few fragmentary reports on the ecology
and epidemiology of rickettsioses in North Africa.6—8 In
Algeria, MSF due to R. conorii has been the sole human
tick-borne rickettsiosis known by clinicians, although tick-
borne rickettsial agents other than R. conorii have recently
been detected in ticks, including Rickettsia aeschlimannii
and Rickettsia massiliae. We report herein a prospective
study conducted in Oran, the second largest city in Algeria.
Methods
Patients
All patients seen at the infectious diseases consultation
department of the Oran Teaching Hospital with a suspicion
of rickettsiosis (high fever, skin rash, headache, myalgia,
arthralgia, and/or eschar) during the period between Jan-
uary 2004 and December 2005 were included in the study.
Clinical and epidemiological data, laboratory results, treat-
ments, and outcome were collected on a standardized form.
A severe form of the disease was defined in hospitalized
patients by extracutaneous organ dysfunction of at least one
organ (neurological signs, renal insufficiency, shock, respira-
tory failure, etc.).9,10 Informed consent was obtained from
all patients.
Laboratory procedures
For each patient, an acute-phase serum sample was obtained
within 2 weeks after the onset of symptoms and, when
possible, a convalescent-phase serum sample (collected 1
to 2 weeks later) was also obtained. Sera were sent to the
World Health Organization (WHO) collaborative center for
rickettsial diseases in Marseille, France. IgG and IgM antibody
titers were estimated by the immunofluorescence (IF) assay,
using nine spotted fever group rickettsial antigens (R. conorii
conorii, R. conorii israelensis, Rickettsia africae, Rickettsia
sibirica mongolotimonae, R. aeschlimannii, R. massiliae,
Rickettsia helvetica, Rickettsia slovaca, and Rickettsia felis)
and a typhus group antigen, Rickettsia typhi.11 The rationale
for the antigen screening panel was supported by the pre-
sence of rickettsial species or subspecies in the Mediterra-
nean area. The IF assay was considered positive if: (1) IgG
titers were 128 and/or IgM titers 64 for R. conorii and (2)
IgG titers were64 and/or IgM titers32 for other rickettsial
antigens.11,12 When cross-reactions were noted betweenseveral rickettsial antigens, the standard procedure of the
Unite´ des Rickettsies was followed. This includes Western
blotting and cross-adsorption studies to complement the IF
assay, and is comprised of three steps:13 (1) A rickettsial
antigen was considered to represent the infectious agent if
titers of IgG and/or IgM antibody against this antigen were at
least two-fold higher than titers of IgG and/or IgM antibody
against other rickettsial antigens. (2) When the difference in
titers between several antigens was lower than two-fold,
Western blot assays were performed. A rickettsial antigen
was considered to represent the infectious agent if acute-
phase or convalescent-phase sera reacted only with its spe-
cific antigens. (3) When Western blot assays were not diag-
nostic and IgG/IgM titers were 128/32, cross-absorption
studies were performed. Specific diagnostic criteria after
cross-absorption studies included: (a) positive IF serologic
test results for a single antigen or (b) a Western blot assay
showing exclusive reactivity with the specific proteins of a
single agent.
Inoculation eschars were biopsied and frozen at 70 8C or
kept in ethanol. Histologic analyses and immunohistochem-
ical detection were performed as described previously.14,15
Attempted cultivation of rickettsiae from skin biopsy speci-
mens was performed using the shell-vial cell culture techni-
que.13,14 DNA was extracted from ground eschar biopsy
specimens by use of the QIAamp tissue kit (Qiagen GmbH,
Hilden, Germany), according to the manufacturer’s recom-
mendations. These extracts were used as templates in pre-
viously described PCR assays incorporating the primers 190—
70 and 190—701, which amplify a 630-bp fragment of the
ompA gene of SFG Rickettsia spp.14,16 As negative controls,
we used sterile water processed as described above, and DNA
extracted from the heart valve of a patient with degenera-
tive valvulopathy was incorporated into every six specimens.
As a positive control, we used DNA from Rickettsia monta-
nensis. The sequences of all positive PCR products were
obtained, assembled, edited, and compared to those avail-
able in GenBank using a BLAST search, as previously
described.16 Clinical and epidemiological data were entered
into and analyzed with EpiInfo version 6 (Centers for Disease
Control and Prevention, Atlanta, GA, USA).
Results
Mediterranean spotted fever confirmed cases
A total of 277 patients were included in the 2-year study,
including 51% patients living in the city of Oran and 49% in
surrounding rural areas. Most of the patients (80%) were
included during the summer months from July to September.
Half of the patients had received beta-lactam antibiotic regi-
mens before being included in the study. Among the 277
patients included in this study, serum samples of 248 patients
were studied. Among these patients, 191 (77%) had raised
antibodies against SFG rickettsial antigens. After the Western
blot and cross adsorption assays, a total of 161 cases were
definitely confirmed to be R. conorii infections (Figure 1). The
species involved could not be determined for 27 cases. Skin
biopsy fragments of inoculationescharswere obtained from44
cases. A total of 29 were positive by PCR, including those from
six patients who tested negative by IF using their early course
Figure 1 Western blot assay and cross adsorption studies of an immunofluorescence-positive serum sample from a patient with
rickettsiosis in Algeria. Antibodies were detected at the highest titer (IgG 64/512 IgM) for both R. conorii and R. typhi antigens.
Columns Rc and Rt: Western blots using R. conorii and R. typhi antigens, respectively. MW:molecular weights are indicated on the left.
When adsorption is performed with R. conorii antigens (column Ads with Rc Ag), it results in the disappearance of the signal from
homologous and heterologous antibodies, but when it is performed with R. typhi antigens (column Ads with Rt Ag), only homologous
antibody signals disappear, indicating that the antibodies are specific for R. conorii.
Figure 2 Immunohistochemical detection of Rickettsia conorii
(in red) in the inoculation eschar of a patient with spotted
Mediterranean fever (rabbit anti-R. conorii antiserum used at
1:1000 dilution and hemalun counterstain, original magnification
200).
Mediterranean spotted fever in Algeria 229serum. Sequencingof positivePCRproducts confirmed that the
patients were infected with a Rickettsia spp and the nucleo-
tide sequences of the rOmpA gene fragment were 100% similar
to the corresponding sequence of R. conorii conorii strain
Malish (GenBank accession number U83453). Immunohisto-
chemical detection of R. conorii was positive in 20/44 biopsy
fragments (Figure 2). Cultures from skin biopsies were positive
in eight cases and R. conorii was isolated in all of the cases.
Using all these techniques, a total of 167 cases of MSF due toR.
conorii were diagnosed. These confirmed cases are described
below.
Epidemiological and clinical characteristics
Except in children younger than 10 years old, patients with
confirmed MSF were predominantly male. The mean age of
the patients was 38.1  2.7 years (range 0—80 years). Prior to
the consultation, 89 patients (53.3%) had received antibiotics
and 29 (17.4%) had received corticosteroids.
A total of 159 (95.2%) of the patients reported contact
with dogs, 84 (50.3%) patients reported tick bites, and the
tick was still on 17 (10.2%) of the patients at the time of the
consultation. Most contaminations (80%) had taken place
around the home. Underlying conditions were present in
73 (43.7%) patients and included diabetes (7%), tobacco/
alcohol consumption (14%/3%), high blood pressure (7.6%),
cancer, valvulopathy, asthma, and a history of myocardialinfarction. The mean interval of time between the first
symptom and the consultation was 6.4  4 days (range of a
few hours to 23 days). The incubation time was estimated in
22 patients who remembered the date of the tick-bite; it was
6.6  2.1 days.
230 N. Mouffok et al.A generalized maculopapular rash frequently including
the palms and soles was seen in 164 patients (98.2%)
(Figure 3), and included purpuric elements on the legs in
25 cases (15.0%) (Figure 4). The presence of an inoculation
eschar (73.7%) was most often observed on the trunk and
legs. Of interest, 14 patients had two eschars and six had
three eschars (Figure 5). Conjunctivitis was present in 78
cases (46.7%) and was unilateral in four patients (Figure 6).
Other clinical findings of our 167 patients with confirmed MSF
are presented in Table 1. Electrocardiograms (ECG), which
were performed for 107 patients (64.1%), were abnormal in
19 patients (17.8%), including problems with repolarization
and conduction, and signs of myocarditis in 11 cases (10.3%).
Echography was done in 29 patients, resulting in a diagnosis
of pericarditis in three cases (1.8%). Chest X-ray findings
included: interstitial infiltrates in 35 cases (21.0%), atypical
pneumopathy (four cases), pleural effusion (two cases),
and pulmonary edema (two cases). Thrombocytopenia
(<150  109/l) was found in 45 patients (26.9%). Serum
elevated liver enzymes, AST and ALT, were found in 72
(50.7%) and 79 (55.6%) of the patients, respectively, hypona-
tremia in 55 (70.5%), and low blood cell count (<4  109/l) in
20 patients (12.0%).Outcome
Most patients (80.8%) were treated with doxycycline
(200 mg/day for 3—8 days), while other patients were trea-
ted with a macrolide antibiotic (josamycin; 15.6%, including
24 children and two pregnant women), chloramphenicol
(1.8%), and fluoroquinolones (1.8%). The outcome was favor-
able for 161 patients (96.4%). A discrete skin desquamation
was observed in 99 patients (59.3%). Apyrexia appeared after
a mean of 2.6 days (range 1—7 days). Asthenia and myalgia
persisted anywhere from a few weeks to 6 months (72%).
A total of 82 (49.1%) of the 167 patients with confirmed R.
conorii infection were hospitalized with a severe form of the
disease. Of these severe cases, 11, including 10 men, pre-
sented major neurological manifestations and multiorgan
involvement. The mean age of these 11 patients was 56.7
years. Underlying conditions and comorbidities were noted,
including chronic tobacco smoking (6/11), chronic alcohol-Figure 3 Typical maculopapular rash in two patients with Mediterr
Algeria, 2004—2005. Note the fact that the rash may include palmsism (2/11), diabetes associated with high blood pressure (3/
11), and high blood pressure (1/11). Purpuric elements
accompanied the rash in six patients. Finally, six patients
out of 11 (54.5%) died despite administration of doxycycline
or fluoroquinolones. The overall case fatality rate for the 167
patients was 3.6%.
Discussion
MSF is the oldest recognized tick-borne rickettsiosis in the
Old World. It is also known as ‘boutonneuse fever’ because of
the papular rather than macular rash. Although it has long
been known to be endemic in the Mediterranean area, the
first cases were clinically recognized in the University Hos-
pital of Oran in 1993, as this diagnosis was absent from the
records of the Hospital before that time. Interestingly, since
that time, an increasing number of cases have been reported
in hospital records, reaching 202 cases in 2005. This increased
incidence prompted the performance of this study, together
with entomological surveys,17,18 in order to better describe
MSF in Algeria and, more generally, in North Africa.
We report here the largest prospective study conducted
on clinical and epidemiological aspects of spotted fever
group rickettsioses in North Africa. This 2-year study con-
ducted in Algeria, including an intermediate publication,11
reports the first cases definitively documented by the use of
reference methods, including IF serology complemented by
Western blotting and absorption studies, isolation in culture
by the shell-vial techniques, and molecular tools. Out of 277
patients clinically suspected of having a SFG rickettsiosis, 167
(60.3%) were definitely documented as having MSF caused by
R. conorii.
In this study, some aspects of MSF were found to be in
accordance with the usual epidemiology of this disease.
Cases were encountered in the summer, with most cases
diagnosed between July and October, when the brown dog
tick vectors R. sanguineus are most aggressive.19 Similarly,
in southern Europe, most samples submitted for diagnosis of
rickettsioses are received between July and September.20,21
It should be noted that although R. sanguineus is well-
adapted to urban environments, it is relatively host-specific
and rarely feeds on people unless its preferred host (theanean spotted fever (MSF) caused by Rickettsia conorii in Oran,
, as shown in patient A.
Figure 4 Purpuric rash with vasculitis in a severe form of Mediterranean spotted fever (MSF) caused by Rickettsia conorii in Oran,
Algeria.
Mediterranean spotted fever in Algeria 231domestic dog) is not available. This is probably why the
incidence of MSF is relatively low in endemic areas, despite
close contact between people, dogs and their ticks.1 How-
ever, the curiosity of clinicians and their specific interest in
rickettsioses are probably not the sole explanation for the
increase in the number of reported cases in Oran since 1993,
particularly between 2000 and 2006. An increased aggres-
siveness of the ticks to bite humans,maybe linked to climatic
changes, could be hypothesized. A similar increase in the
number of MSF cases was observed in southern Europe during
the 1970s.22 This increase in incidence was correlated with
higher temperatures and lower rainfall in Spain and with a
decrease in the number of days of frost during the preceding
year in France.23 More recently, maximum temperature
levels during the previous summer were found to be asso-
ciated with increases in MSF incidence in Sardinia.24 In
northwestern Algeria in 2002—2003, the weather was char-acterized by higher annual minimal and average tempera-
tures (higher than the preceding record in 1998), a cold and
rainy winter, a longer dry season (7—8 months, starting in
March), and a particularly warm summer. In 2003, the high-
est summer temperatures in the past decades were noted in
Oran. We hypothesized that the host-seeking and feeding
behaviors of these tick vectors were altered by these parti-
cular climatic circumstances, as demonstrated for other tick
species.25,26 This could also be linked to the clinical aspects
reported herein. Indeed, of interest, 20/123 (16.3%)
patients with eschars had multiple taˆche noire. This is quite
unusual in MSF. Indeed, the typical inoculation eschar at the
tick-bite site, the hallmark of many SFG rickettsioses, was
described in 1925 as usually being unique in MSF.27 In con-
trast, there are often multiple eschars in a few other tick-
borne rickettsioses because of the aggressive behavior of
the tick vectors. Moreover, these more aggressive ticks are
Figure 5 Inoculation eschars (taˆche noire) in three patients with Mediterranean spotted fever (MSF) caused by Rickettsia conorii in
Oran, Algeria, 2004—2005. (A) Single eschar, the most common feature in MSF; (B) two eschars; (C) three eschars, a rare finding in MSF,
accompanied with a maculopapular rash.
232 N. Mouffok et al.related to a high Rickettsia infection rate. Examples of
rickettsias caused by these aggressive ticks include the
African tick-bite fever caused by R. africae in sub-Saharan
Africa28 and the infection caused by R. sibirica mongoloti-
monae.14 In the case of R. sanguineus, in addition to its low
tendency to bite people, there is a low prevalence of
infected ticks with R. conorii, frequently lower than 1%.1
Again, modification of the behavior of the vectors resulting
from climatic changes could explain these aspects of the
disease. Similarly, in 2003, we found 22 R. sanguineus
attached to an alcoholic homeless man who later died ofFigure 6 Ocular manifestations in two patients with Mediterranean
2004—2005. (A) Unilateral conjunctivitis; (B) red-free fundus photogr
retinal lesions due to a chorioretinitis.MSF. He was living with his dog near Marseilles. The tem-
perature was particularly high in Marseilles that summer.29
Also, in the summer of 2007,we investigated a focus of MSF in
southern France. A garden that was invaded by hundreds of
aggressive R. sanguineus was found to be the source of the
cases. For this group of cases, people reported having sev-
eral tick bites, several times between May and July (Parola
et al., personal communication).
Apart from the inoculation eschars, other clinical aspects
were in accordance with the description of the disease,
including a 6- to 7-day incubation period, an abrupt onset,spotted fever (MSF) caused by Rickettsia conorii in Oran, Algeria,
aph and (C) color fundus photograph showingmedium-sized white
Table 1 Clinical findings in 167 patients with confirmed Med-
iterranean spotted fever caused by Rickettsia conorii in 2004—
2005; Oran, Algeria
Clinical findings n %
Abrupt onset 142 85.0
Moderate altered state
of health
81 48.5
Much altered state
of health
22 13.2
Fever 167 100
Loss of weight 119 71.3
Asthenia 154 92.2
Headache 159 95.2
Arthromyalgia 148 88.6
Cutaneous signs
Maculopapular rash 164 98.2
Purpuric rash (legs) 25 15.0
Extensive purpuric skin 3 1.8
Discrete eruption 72 43.1
Taˆche noire
(inoculation eschar)
123 73.7
Single 103
Double 14
Triple 6
Neurologic signs
Meningitis 8 4.8
Altered state of
consciousness
18 10.8
Coma 6 3.6
Delirium 6 3.6
Seizure 8 4.8
Agitation 8 4.8
Hemiparesis 3 1.8
Hemiplegia 1 0.6
Tetraparesis 2 1.2
Cerebellar ataxia 4 2.4
Pyramidal syndrome 2 1.2
Peripheral neuropathy 7 4.2
Bilateral hypoacusis 3 1.8
Unilateral hypoacusis 5 3.0
Digestive signs
Vomiting 120 71.9
Diarrhea 14 8.4
Constipation 32 19.2
Abdominal pain 29 17.4
Gastric and duodenal
ulceration
5 3.0
Ictus 3 1.8
Hepatomegaly 13 7.8
Splenomegaly 7 4.2
Cardiovascular signs
Shock (systolic blood pressure
<90 mmHg and tachycardia)
12 7.2
Deep venous thrombosis (leg) 2 1.2
Table 1 (Continued )
Clinical findings n %
Nephrological signs
Oliguria—anuria 7 4.2
Edema
On leg 45 26.9
On legs and arms 4 2.4
Respiratory signs
Cough 58 34.7
Respiratory insufficiency 5 3.0
Thoracic pain 6 3.6
Epistaxis 7 4.2
Adenopathy 9 5.4
Ocular signs
Conjunctivitis 78 46.7
Bilateral 74
Unilateral 4
Chorioretinitis 1 0.6
Uveitis 1 0.6
Hemorrhagic conjunctivitis 3 1.8
Papillary edema 4 2.4
Hemorrhagic retinitis 2 1.2
Death 6 3.6
n = number of patients positive for the finding.
Mediterranean spotted fever in Algeria 233high fever, loss of weight, headache, arthromyalgia, and a
typical maculopapular rash that often involved the palms and
soles, but spared the face. Also, in 2.4% of the cases, the
inoculation occurred through conjunctivae and patients pre-
sented with unilateral conjunctivitis. Different aspects of the
rash have been reported, including purpuric forms, particu-
larly in severe cases. Three cases of retinitis or chorioretinitis
(Figure 6), an infrequently reported condition for MSF,30 were
also found. However, in addition to the panel of clinical
aspects of MSF, this high frequency of severe forms is unusual.
MSF had been named ‘benign summer typhus’, until severe
forms were described in 1982, with the report of six patients
with severe forms of MSF, including four deaths.31,32 In 1983—
1984, active surveillance of MSF in Marseille and the sur-
rounding area identified 5% of patients with a severe form of
the disease.9 Classic risk factors for severe forms include
advanced age, immunocompromised situations, chronic alco-
holism, glucose-6-phosphate dehydrogenase deficiency, prior
prescription of an inappropriate antibiotic, or delay of treat-
ment.33 In 1997 in Beja, a Portuguese southern district, the
case fatality rate in hospitalized patients with MSF was
32.3%; this is the highest rate documented at this site since
1994. Interestingly, when risk factors for fatal outcome were
studied in 105 patients hospitalized between 1994 and 1998,
the risk of dying was significantly associated with diabetes,
vomiting, dehydration, and uremia.34 Some differences have
been noted in the severity of MSF in different areas, even in
the same country.1
In our series, the prevalence of severe forms of MSF was as
high as 49.1%, and 6.6% of the 167 patients presented with
234 N. Mouffok et al.neurological symptoms, multiorgan involvement, and a 50%
death rate. To date, we do not have an explanation for this
high frequency of severe forms. It should be noted that half of
the patients who were recruited for the study had received
beta-lactam antibiotic regimens, which are ineffective for
the treatment of rickettsioses.
Conclusions
The present report gives a unique panel of clinical aspects of
MSF, the most important tick-borne disease in North Africa.
We have also presented new trends of this disease in north-
western Algeria. Entomological and climatic studies would
help to test the hypothesis that a modification of the tick
vector life cycle or behavior explains the increased incidence
of cases, and may provide a link between the behavior or
lifecycle changes and the increased number of severe forms
that have been seen by clinicians in recent years. Also,
complementary studies on the strains responsible for the
cases in Oran, based on genotyping, could also test the
hypothesis that particular strains of R. conorii are involved
in severe forms of the disease.
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